Research and analysis

Herpes zoster (shingles) immunisation programme 2016 to 2017: evaluation report

Evaluation of the fourth year of the shingles vaccination programme in England from 2016 to 2017.

Documents

Herpes zoster (shingles) immunisation programme report: September 2016 to August 2017

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Shingles vaccine coverage in England by age cohort, Clinical Commissioning Group and Local Authority: 1 September 2016 to 31 August 2017

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The shingles vaccination programme aims to reduce the incidence and severity of shingles in those targeted by the programme by boosting individuals’ pre-existing varicella zoster virus immunity.

This report highlights the lower coverage achieved in the routine and catch-up cohort in 2016 to 2017 compared with previous years. GPs are urged to continue to offer vaccinations to these cohorts as per current guidance, to improve protection in these age groups.

In the fourth year of the programme (2016 to 2017), the vaccine was offered to adults:

  • aged 70 years on 1 September 2016 (born between 2 September 1945 and 1 September 1946)
  • aged 78 years on 1 September 2016 (born between 2 September 1937 and 1 September 1938)

The eligibility criteria for shingles vaccine changed from 1 April 2017.

Last year’s report for comparison.

Published 15 December 2017